Morning Overview on MSN
Study links healthier thymus to lower death and disease risk
Researchers analyzing chest CT scans from more than 27,000 adults have found that the condition of the thymus gland, a small ...
Soligenix Announces HyBryte™ Clinical Summary Published in “Expert Opinion on Investigational Drugs”
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Revenue and outlook: Seer reported Q4 revenue of $4.2M and FY 2025 revenue of $16.6M (+17% YoY) but missed expectations due to project delays tied to NIH funding Commercial traction and product ...
As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) ...
Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...
Ask a clinical question and tap into Healio AI's knowledge base. In contrast to incidence, the USCS and SEER-18 data revealed an increase in NSCLC prevalence from 2010 (175.3 per 100,000) to 2016 (198 ...
Ottawa Citizen on MSN
St. Paul presented an animated and lively production of Something Rotten! Jr. | Cappies
Show # 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results